SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

AGM Trading Statement

26 Apr 2023 07:00

RNS Number : 4316X
Elementis PLC
26 April 2023
 

Elementis plc

AGM Trading Statement

 

Resilient first quarter trading performance, in line with expectations

 

Materially improved Talc performance, continued benefits from self-help actions

 

 

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 March 2023.

First Quarter Business Performance

 

Overall trading for the three months ended 31 March 2023 has been resilient against continued subdued market demand conditions. Revenue was flat on an underlying basis against a strong prior year period, as the benefits from prior year pricing actions and improved mix broadly offset weaker volumes, primarily in Coatings.

· In Performance Specialties, underlying performance was below the prior year period due to continued challenging demand conditions across coatings markets against a very strong prior year comparative. Talc performance materially improved driven by the benefits of pricing actions and improved mix. Overall, Performance Specialties pro-forma margins were modestly below the prior year period.

 

· Personal Care underlying performance improved on the prior year period. Volumes were broadly stable as new product launches and new business success helped to offset market weakness in Asia. Margins remained strong due to successful pricing actions and improved mix.

 

Cash generation in the first quarter was in line with expectations, with the completion of the Chromium disposal providing a one off benefit. The Group's business model remains highly cash generative.

 

Outlook

 

The year has started as expected with the benefits from self-help and pricing actions offsetting market related volume softness in Coatings. For the full year, we are confident that further strategic progress will drive improved financial performance and a further reduction in leverage, in line with expectations.

 

The Group will hold a Capital Markets Day in November which will outline the next stage of our strategic development. Further details will be communicated in due course.

 

Commenting on today's announcement, CEO, Paul Waterman said,

 

"We have made a solid start to the year and will continue to maintain our focus on self-help actions and effectively managing the challenging demand environment. We remain on-track to deliver over $50m of new business opportunities, 15 new products and progress towards $10m of additional efficiency savings by year end."

 

 

Enquiries

Elementis

James Curran, Investor Relations 07342 999067

Teneo

Martin Robinson 020 7353 4200

Olivia Peters

 

Note: Underlying basis means adjusted for constant currency impact

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSESVIEFIV
Date   Source Headline
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.